Low back pain (LBP) is a serious debilitating condition that presents detrimental socioeconomic implications, affecting 80% of the general population at some point in time.
Anatomy and Physiology of the Intervertebral Disk
The intervertebral disks separate the vertebral bodies to facilitate load transmission and multiaxial flexibility while playing the role of "shock absorber" in response to dynamic spinal compression. Moreover, the disk acts as a "spacer" by providing height to the spinal column, allowing passage of nerves through the intervertebral foramen and facilitates biomechanical synergy with the posterior facet joints.
The intervertebral disk consists of an inner gelatinous core (nucleus pulposus) and a thick outer ring of fibrous cartilage (annulus fibrosus; ►Fig. 1). The nucleus pulposus is mainly composed of a proteoglycan and type II collagen in a ratio of 20:1. The proteoglycans are hydrophilic in nature, thereby creating a swelling pressure that provides compressive stiffness to the disk. 28 , 29 The annulus fibrosus serves as an intervertebral ligament composed of up to 25 concentric collagen lamellae that provide bending and shear stiffness/ strength. 28 The nucleus is separated from the adjacent vertebra by the end plate, which is a thin bilayer of cartilage and porous subchondral bone. The end plate balances two conflicting requirements of being porous to facilitate transport between nucleus cells and vertebral capillaries and being stiff to resist axial compressive loads.
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Early degenerative processes include enzymatic degradation of nucleus proteoglycans that leads to decreased swelling and reduced disk water. These changes are brought upon by age progression and excessive physical loading, 31 which adversely affect disk biomechanics leading to altered tissue stress distributions and biological activities that in turn cause nuclear fibrosis and disorganization of the annular architecture (►Fig. 2). [19] [20] [21] [22] [31] [32] [33] Biochemical changes of the extracellular matrix and damage accumulation at the disk periphery trigger inflammatory cellular responses that promote a cascade of further structural modifications that progressively compromise disk biomechanics. 31, 34, 35 Furthermore, progression of disk degeneration may also be associated with end plate and subchondral bone edema (e.g., Modic changes) that can further contribute to the development of pain. [36] [37] [38] In fact, overweight/obesity has also been implicated with end plate and Modic changes of the lumbar spine.
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Disk Degeneration and Low Back Pain
For the past two decades, magnetic resonance imaging (MRI) has been the gold standard for assessing intervertebral disk degeneration in vivo. [42] [43] [44] Although there have been numerous classification schemes proposed to assess disk degeneration on MRI, many investigators have traditionally referred to the Pfirrmann or the Schneiderman criteria, 42,43 both of which rely on signal intensity of the disk on imaging to denote grades of degeneration severity. In one of the earliest spine degeneration MRI studies, Boden et al noted in 67 subjects that disk degeneration is quite common, even in asymptomatic individuals. 45 These and other observations raised questions regarding associations between disk degeneration assessed by anatomic imaging and clinical symptoms. However, more recent studies based on large populations (over 2,500 Southern Chinese subjects) have shown that disk degeneration on MRI is significantly associated with LBP history in adults, and such an association increases according to the global severity of disk degeneration (i.e., degenerative disk disease score). 46 Samartzis et al have also noted that disk degeneration severity in asymptomatic individuals is predictive for future first-time LBP episodes. 47 These trends appear generalizable as Takatalo et al have noted for the Northern Finnish Birth Cohort that the severity of disk degeneration on MRI is associated with the severity of low back symptoms over a 3-year period in young adults. 18 What's more, a systematic review by Chou et al, addressing the association of disk degeneration on MRI and symptoms in various populations throughout the world, observed a significant association between disk degeneration and chronic LBP.
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Body Mass Index and Lumbar Disk Degeneration
Although body weight has been noted to be associated with the development of cardiovascular disease, diabetes, and malignancies among other conditions, its effects upon disk degeneration have remained elusive. The nature of this is largely attributed to the lack of large epidemiologic studies with a proper study design, patient-based studies, insufficient statistical analyses, mode of radiographic/imaging assessment in defining the phenotype of disk degeneration, and/or conjecture arising from limited radiographic interpretation of additional spinal findings (e.g., Schmorl nodes) that may contribute to the degenerative process. 12,48-52 Furthermore, the association of overweight and obesity with the extent (i.e., levels with disk degeneration) and severity of disk degeneration of the lumbar spine remain unknown because previous studies have failed to quantitatively assess such parameters on advanced imaging. However, because overweight and particularly obesity have been associated with LBP, 23 and because disk degeneration on MRI is an etiologic factor related to LBP, 14, 16, 17 it would appear reasonable that elevated BMI may be instrumental in the development of disk degeneration. It should be noted that BMI cutoff values denoting overweight or obesity do vary between ethnic populations.
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According to a meta-analysis by Shiri et al, obesity, as measured by BMI, is significantly associated with LBP. 23 However, to date, the relationship between body weight and disk degeneration has been contentious. In a study of 270 elderly Japanese individuals, Hangai et al noted that high BMI values presented a risk in developing disk degeneration based on MRI. 48 According to Liuke et al in their study of 129 middle-aged Finn males, obesity was associated with the development of disk degeneration. 51 Conversely, according to the Rotterdam Study, which is a population-based study entailing Dutch subjects, a cross-sectional analysis of 2,819 individuals 55 years and older who underwent X-ray assessment did not note any association between elevated BMI and disk space narrowing. 12 Similarly, based on the findings of the Chingford Study population of 1,003 elderly women from the United Kingdom, a prospective longitudinal assessment noted only a potential trend between elevated BMI values and the development of disk space narrowing on plain radiographs. 49 According to the Framingham Study, a cross-sectional analysis of 187 North American subjects who underwent computed tomography to assess spinal degenerative changes noted in obese subjects a higher prevalence of facet joint osteoarthritis but without disk space narrowing.
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According to Videman et al in their assessment of 44 pairs of male monozygotic twins from the Finnish Twin Cohort who had 8-kg or greater discordance in body weight between siblings, disk degeneration (based on quantitative signal variation in MRI) was not associated with overweight or obesity. 52 In fact, the authors concluded that greater body mass "is not harmful to the disk" and that it may "delay" disk degeneration. However, due to the 8-kg discordance in body weight and small sample size, this may not be an effective manner in assessing the effects of overweight or obesity upon disk degeneration because there may be incomparable groups comparing various BMI categories. Based on a study by Samartzis et al, which was composed of 2,599 Southern Chinese subjects ranging in age from 21 to 63 years, the authors noted a significant association between elevated BMI values, in particular obesity, and the overall presence of lumbar disk degeneration and number of degenerative levels, global severity of degeneration, and end-stage disk degeneration with disk space narrowing in MRI. 22 In a particular seminal finding, the authors noted a significantly positive linear trend association between BMI and disk degeneration of the lumbar spine, where individuals who were overweight and obese presented with an increased likelihood of having disk degeneration (30 and 80%, respectively) in comparison with normal-weight individuals. Endstage disk degeneration with disk space narrowing is often coupled with degenerative changes throughout the vertebral motion segment (e.g., canal and neuroforaminal stenosis, ligamentous thickening) and altered lumbar kinematics that increase the risk of LBP. 12 Such severity of disk degeneration may help explain the increased prevalence of prolonged and chronic LBP in overweight and obese individuals concluded in the recent meta-analysis.
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Even though overweight and, in particular, obesity are influential factors related to disk degeneration, the exact mechanism of this association remains speculative. For numerous years, it has been postulated that overweight and obesity contribute to disk degeneration by excessive compressive loading. However, recent studies have noted a linear association between hand osteoarthritis and atherosclerosis in elderly females. 54, 55 Such findings are independent of increased loading effects that could be brought upon by body weight and contradict that overweight and obesity contributes to osteoarthritis only via altered biomechanics. The explanation for this phenomenon may be mediated by an inflammatory response by secondary mediators secreted by adipocytes, such as adipocytokines (e.g., adiponectin, leptin, resistin), macrophage-derived factors (e.g., interleukin [IL]-1β), or proinflammatory cytokines and chemokines (e.g., C-reactive protein, tumor necrosis factor-α [TNF-α], IL-6). 56 Another potential mechanism may be attributed to vascular insufficiency to the vertebrae and subsequently to the disk brought upon by atherosclerosis or high serum lipids that can diminish nutrient and metabolite transport into the disk. 48, 57 Other possible mechanisms can be attributed to a metabolic disorder or gene-environmental interaction effects.
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Adipokines and Disease
Adipose tissue is a loose connective tissue that is composed of adipocytes or fat cells that store energy in the form of lipids as well as aid in cushioning and insulating the body. Two types of adipose tissue exist, white and brown. Although brown adipose tissue is mainly thought to exist in infants, it can also be found in regions of the neck and the thorax surrounding large blood vessels. As such, the majority of fat cells are white adipose tissue, commonly noted in the abdominal region, thighs, buttocks, and other body parts. The distribution of adipose tissue throughout the body is determined by sex hormones, which explains the predominance of fat distribution in the buttocks and breast regions in females and abdominal fat in males. Nonetheless, small blood vessels, fibroblasts, and macrophages also exist between adipocytes. Besides being a great reservoir for the production of energy, adipose tissue has been recognized as a major endocrine organ that secretes various proteins and hormones that have a direct role in the development of various obesityrelated diseases, such as diabetes type 2 and cardiovascular pathology. With weight gain, macrophages infiltrate the adipose tissue, representing 60% of adipose tissue.
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Adipocytes have numerous receptors, which sense the presence of pathogens and inflammation. Upon receptor stimulation and cross talk with macrophages, the adipocytes activate cascades of inflammatory signal transduction, secreting numerous proinflammatory cytokines (►Fig. 3). These cytokines are key metabolism mediators known as "adipokines." 60 Adipokines have also been implicated as playing a role in the development of numerous conditions, ranging from cerebral (e.g., Alzheimer disease, dementia) to musculoskeletal disorders.
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In 1995, leptin, a key adipokine, was discovered. Since then, research focusing upon adipokines has gained tremendous momentum. To date, over 50 adipokines have been identified, such as adipsin, cathepsin, IL-6, IL-8, leptin, nerve growth factor, retinol binding protein-4 (RBP-4), TNF-α, and thrombopoietin. Assessment of adipokines has been done by high-sensitivity immunoassays either via uniplex or high-throughput multiplex approaches utilizing serum.
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The more common ones, such as leptin, adiponectin, resistin, and RBP-4, have been thoroughly addressed in the literature with respect to their role with obesity-related diseases.
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These adipokines have been noted to be markers for glucose homeostasis, to regulate adipose tissue and body weight, to cause immune dysfunction, to affect metabolism, to stimulate energy expenditure, and to play a role in bone formation/ function and local/systemic inflammatory states. 68 Increased serum level of leptin is directly associated with obesity and is suspected to be involved in reorganizing the cytoskeleton of nucleus pulposus cells; thus, altering the disk organization and structure. 69, 70 This leads us to believe that leptin is involved in the pathogenesis of disk degeneration. Based on a study by Dumond et al, high leptin levels, independent of BMI, have been associated with the development of knee osteoarthritis in humans. 71 Increased levels of leptin have been found in knee cartilage destruction, suggesting that adipokines may play a critical role in the pathophysiology of osteoarthritis. Leptin has been noted to increase production of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 in knee cartilage, contributing to the catabolic effects of osteoarthritis. 72 Other adipokines (e.g., adiponectin) have also been implicated in the development and severity of knee osteoarthritis.
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In a study by Yusuf et al assessing the role of serum leptin, resistin, and adiponectin in the radiographic progression of hand osteoarthritis during a 6-year follow-up, the authors noted that adiponectin had an independent role from other risk factors in the progression and pathophysiology of disease. 75 Recent studies have also noted that adipokine levels (e.g., leptin, visfatin, resistin, adiponectin, TNF-α, IL-6), independently of BMI, were predictive for the radiographic progression of rheumatoid arthritis over a 4-year period. 76 In fact, studies have also noted that ratios of various adipokines (e.g., adiponectin/leptin) may predict knee pain severity in subjects with osteoarthritis.
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Studies have shown the adipokines, such as leptin, may be associated with cardiometabolic risk and may predict metabolic syndrome; as such, early identification of adipokines may lead to an early diagnosis or prevention of the metabolic syndrome. 78 The effects upon disease of these adipokines may also be synergistic with the presence of altered metabolism (e.g., metabolic syndrome), which may propagate or hinder their effect. For example, according to a study by Shah et al assessing adipokines and fat compositions in South Asian subjects, the authors noted that leptin levels may increase with an increase in adiposity, whereas adiponectin may also be mediated by metabolic factors (i.e., high-density lipoprotein, triglycerides, and glucose).
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Adiposity, Adipokines, Lumbar Disk Degeneration, and Low Back Pain
Recently, numerous studies have surfaced that provide a firm foundation connecting the association between adipose tissue activity, or rather adipokine secretions, to that of disk degeneration and LBP. Urquhart et al conducted a study in 135 individuals assessing body composition via dual radiograph absorptiometry and the association with LBP intensity and disability. 80 The authors concluded that body fat and not lean tissue mass was significantly correlated with a higher LBP intensity and worse disability. Although some may argue that an increase in fat mass or adiposity, in particular at the abdominal region, may increase the stress and strain upon the lower spine thereby contributing to degenerative changes of the disk, one may argue against this notion. For one, Urquhart et al have noted a significant independent relationship between an increase in body fat of the extremities in relation to LBP. 80 Second, studies have noted that obesity is a risk factor for osteoarthritis of the hand, which is a nonweight-bearing region.
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Macrophage-secreted proinflammatory cytokines are found in disk degeneration, which contribute to the degradation of the disk's matrix. Furthermore, in discogenic LBP individuals, such cytokines are found in the disk affecting the ingrowth of nerve fibers, a process that contributes to pain generation. Studies by Zhao et al and Gruber et al assessing human disk tissue have noted leptin receptors in the disk, concluding that leptin can lead to cell clustering and disk degeneration. 83, 84 Studies have also noted that increasing leptin levels may increase bone mineral density of the vertebral bodies, which may affect the adaptive response by the disk to accommodate the increased stress stemming from the altered bone mineral density state of the adjacent vertebrae. Cadaveric disk tissue assessment has also found the presence of cathepsin, an adipokine, in the disk and noted its role in degradation of the matrix and disk degeneration.
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Moreover, cathepsin expression has been noted in vertebral end plate cartilage destruction and sclerosis in mice. 87 Studies have also noted inflammatory cytokines (e.g., TNF-α, IL-6) in degenerated facet joints. 88 As such, it is extremely plausible that systemic metabolic and/or inflammatory mediators released from adipokines may play a role in the development of disk degeneration and subsequently LBP (►Fig. 3).
Based on the population-based cohort study of Southern Chinese subjects reported by Samartzis et al, following adjustment for age, gender, work load, and other factors, overweight and obesity based on BMI were significantly associated with the development and severity of lumbar disk degeneration. 22 Furthermore, based on this cohort, males presented with a higher risk of disk degeneration than females. It is worth noting that adiposity deposition is greater in the abdominal region for males than it is for females, which may elaborate as to the propensity of disk degeneration prevalence among males. Moreover, based on this study, there were individuals who were regarded on BMI as overweight and obese who did not have disk degeneration. In a population-based study assessing a Finnish cohort of young adults, Takatalo et al noted that an increase in abdominal obesity measured on sagittal MRIs was associated with a severity of disk degeneration in young males (►Fig. 4).
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Being mindful that abdominal obesity is a significant factor associated with increased adipokine levels, such a study presents seminal findings that adipokines may play a role in lumbar disk degeneration. As such, it may be plausible that an increase in abdominal fat may lead to an increase in adipokine secretion of proinflammatory cytokines and metabolic mediators that may contribute to spinal degeneration by introducing inflammatory changes or increasing their expression in the disk.
Altered Metabolism and Endothelial Compromise in Disk Degeneration
The role of improper vascular supply or metabolism in the mechanistic pathway of disk degeneration has been under heated debate and interest. Although the intervertebral disk in adults is one of the largest avascular structures in the human body, it receives nutrients and metabolites from diffusion from the end plate and the vascular plexuses surrounding the disk (►Fig. 5). The end plate is semipermeable and controls diffusion into the disk by moderating the transport of small solutes, such as oxygen, glucose, and sulfate, and prevents loss of macromolecules. 89, 90 Aging, disk geometry, and disk loading have also been implicated in affecting nutrient transport to the disk. 32, [91] [92] [93] In recent years, there has been strong evidence suggesting that if the nutritional supply of the end plate is altered by targeting its microcirculation, the risk of developing intervertebral disk degeneration increases. Studies have noted that altered metabolism may affect the normal integrity of the disk by affecting proteoglycan synthesis, thereby contributing to degenerative changes. 94, 95 Implementing nuclear magnetic resonance spectroscopy, studies have noted that the metabolic marker of lactate production by the disk is associated with discogenic back pain. 96 Other authors have noted that increased serum level of apolipoprotein E is associated with chronic LBP. 97, 98 In addition, occlusion or insufficient arterial blood supply to the lumbar spine due to improper end plate permeability or vascular disorder (e.g., atherosclerotic plaque occlusion) may have direct implications upon the integrity of the intervertebral disk, leading to disk degeneration.
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Advanced Glycation End Products
Advanced glycation end products (AGEs) are chemical compounds that cause irreversible cross-linking in mammalian proteins over time. These substances accumulate in tissues with aging, particularly when the concentration of serum glucose is high, as in diabetes. [99] [100] [101] These compounds tend to be most abundant in collagen and other connective tissue proteins that have a long half-life in vivo. Consequently, AGEs can accumulate in tissues and suppress the expression of aggrecan via acceleration in the receptor for AGEs (RAGE).
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These factors make the intervertebral disk especially susceptible to AGE accumulation and the mechanical effects of collagen cross-linking. For example, both AGE and RAGE have been identified in the nucleus pulposus. 102 Yoshida et al used a bovine model to show that upregulation of RAGE caused a decrease in aggrecan expression at the nucleus pulposus and also the release of proinflammatory cytokines that can lead to matrix breakdown. 103 AGEs are also found to alter biochemical properties, such as the hydrophobicity of the extracellular matrix, possibly reducing hydration of the disk and affecting collagen cross-linking, thereby making the disk stiffer. Using T2-weighted MRI sequences to measure the water content in the intervertebral disks, Jazini et al found a negative correlation between the changes in disk hydration and the accumulation in AGEs.
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Role of Obesity in Spine Surgery Patients
Obesity can increase the technical difficulty and complication rates of surgery due to exposure problems and associated cardiopulmonary disorders. This directly leads to an increase in health care cost with increased length of stay, consumption of resources, and in-hospital morbidity and mortality. showed that 12% of patients with surgical site infections were obese (BMI > 30). 110 In addition, increased skin-tolamina distance and thickness of subcutaneous fat, associated with obesity, were also risk factors for postoperative infections. 110 Similarly, Djurasovic et al reviewed 270 patients and found higher complication rates in the obese group due to wound-related complications. 25 In the Spine Patient Outcomes Research Trial series, patients with obesity (BMI > 30) had higher rates of infection and reoperation and less improvement in symptoms for degenerative spondylolisthesis during the 4-year follow-up. 27 A Swedish study also found that a higher BMI was associated with more dissatisfaction and poorer function and quality of life. 111 For patients with lumbar disk herniation requiring surgery, obese individuals had significantly worse physical function scores on the SF-36 questionnaire and disability profile based on the Oswestry Disability Index in comparison to nonobese patients. 26 This difference was also significant for patients treated nonoperatively. Obesity also increases the risk of recurrent disk herniation ( 10%) after surgery, hypothesized as due to increased and repetitive loading of the operated disk.
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However, the role of adipokines and metabolic dysfunction upon spine surgery outcomes demands further investigation.
Summary
Because overweight/obesity continues to rise in many populations, this could theoretically also increase the prevalence of disk degeneration and LBP. Although evidence is mounting to suggest that lumbar disk degeneration is also part of the spectrum of "obesity-related diseases" as is diabetes and cardiovascular disease, understanding the interaction between genetics, metabolism, environmental factors, and adipokines will broaden the pathophysiologic understanding of disk degeneration. In addition, such an understanding may also aid in predicting the progression of disk degeneration and the development of LBP. As such, preventative measures or targeted therapies for disk degeneration can be developed. Because body fat and its consequences (i.e., altered metabolism) may affect the disk and its disk degeneration profile, potential biological therapies, tissue repair technologies, and even genetic assessment should take into consideration this ongoing risk factor that may contribute to the viability of any new intervention, its efficacy, and outcomes. As such, a more personalized approach to understanding disk degeneration and its treatments considering body fat may be a practical platform that requires further future investigation. 
